230 related articles for article (PubMed ID: 11164418)
1. Overexpression of low density lipoprotein receptor eliminates apolipoprotein B100-containing lipoproteins from circulation and markedly prevents early atherogenesis in apolipoprotein E-deficient mice.
Murayama T; Yokode M; Horiuchi H; Yoshida H; Sano H; Kita T
Atherosclerosis; 2000 Dec; 153(2):295-302. PubMed ID: 11164418
[TBL] [Abstract][Full Text] [Related]
2. Defining the atherogenicity of large and small lipoproteins containing apolipoprotein B100.
Véniant MM; Sullivan MA; Kim SK; Ambroziak P; Chu A; Wilson MD; Hellerstein MK; Rudel LL; Walzem RL; Young SG
J Clin Invest; 2000 Dec; 106(12):1501-10. PubMed ID: 11120757
[TBL] [Abstract][Full Text] [Related]
3. Low density lipoprotein receptor-negative mice expressing human apolipoprotein B-100 develop complex atherosclerotic lesions on a chow diet: no accentuation by apolipoprotein(a).
Sanan DA; Newland DL; Tao R; Marcovina S; Wang J; Mooser V; Hammer RE; Hobbs HH
Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4544-9. PubMed ID: 9539774
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein size and atherosclerosis susceptibility in Apoe(-/-) and Ldlr(-/-) mice.
Véniant MM; Withycombe S; Young SG
Arterioscler Thromb Vasc Biol; 2001 Oct; 21(10):1567-70. PubMed ID: 11597927
[TBL] [Abstract][Full Text] [Related]
5. The two-receptor model of lipoprotein clearance: tests of the hypothesis in "knockout" mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins.
Ishibashi S; Herz J; Maeda N; Goldstein JL; Brown MS
Proc Natl Acad Sci U S A; 1994 May; 91(10):4431-5. PubMed ID: 8183926
[TBL] [Abstract][Full Text] [Related]
6. Phenotype interaction of apobec-1 and CETP, LDLR, and apoE gene expression in mice: role of apoB mRNA editing in lipoprotein phenotype expression.
Nakamuta M; Taniguchi S; Ishida BY; Kobayashi K; Chan L
Arterioscler Thromb Vasc Biol; 1998 May; 18(5):747-55. PubMed ID: 9598833
[TBL] [Abstract][Full Text] [Related]
7. Defective VLDL metabolism and severe atherosclerosis in mice expressing human apolipoprotein E isoforms but lacking the LDL receptor.
Knouff C; Briand O; Lestavel S; Clavey V; Altenburg M; Maeda N
Biochim Biophys Acta; 2004 Aug; 1684(1-3):8-17. PubMed ID: 15450205
[TBL] [Abstract][Full Text] [Related]
8. Constitutive androstane receptor activation decreases plasma apolipoprotein B-containing lipoproteins and atherosclerosis in low-density lipoprotein receptor-deficient mice.
Sberna AL; Assem M; Xiao R; Ayers S; Gautier T; Guiu B; Deckert V; Chevriaux A; Grober J; Le Guern N; Pais de Barros JP; Moore DD; Lagrost L; Masson D
Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2232-9. PubMed ID: 21778422
[TBL] [Abstract][Full Text] [Related]
9. Effects of coexpression of the LDL receptor and apoE on cholesterol metabolism and atherosclerosis in LDL receptor-deficient mice.
Kawashiri M; Zhang Y; Usher D; Reilly M; Puré E; Rader DJ
J Lipid Res; 2001 Jun; 42(6):943-50. PubMed ID: 11369802
[TBL] [Abstract][Full Text] [Related]
10. Serum amyloid A and lipoprotein retention in murine models of atherosclerosis.
O'Brien KD; McDonald TO; Kunjathoor V; Eng K; Knopp EA; Lewis K; Lopez R; Kirk EA; Chait A; Wight TN; deBeer FC; LeBoeuf RC
Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):785-90. PubMed ID: 15692094
[TBL] [Abstract][Full Text] [Related]
11. [Expression profiles of lipid metabolism-related genes in liver of apoE(-/-)/LDLR(-/-) mice].
Du HQ; Yin M; Ye HY; Shang YJ; Dai XD; Jing W; Zhang L; Xiao N; Li JF; Pan J
Zhonghua Bing Li Xue Za Zhi; 2007 Nov; 36(11):751-5. PubMed ID: 18307880
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus-mediated gene transfer of human lipoprotein lipase ameliorates the hyperlipidemias associated with apolipoprotein E and LDL receptor deficiencies in mice.
Zsigmond E; Kobayashi K; Tzung KW; Li L; Fuke Y; Chan L
Hum Gene Ther; 1997 Nov; 8(16):1921-33. PubMed ID: 9382958
[TBL] [Abstract][Full Text] [Related]
13. Inducible ApoE gene repair in hypomorphic ApoE mice deficient in the low-density lipoprotein receptor promotes atheroma stabilization with a human-like lipoprotein profile.
Eberlé D; Luk FS; Kim RY; Olivas VR; Kumar N; Posada JM; Li K; Gaudreault N; Rapp JH; Raffai RL
Arterioscler Thromb Vasc Biol; 2013 Aug; 33(8):1759-67. PubMed ID: 23788760
[TBL] [Abstract][Full Text] [Related]
14. Hepatic lipase overexpression lowers remnant and LDL levels by a noncatalytic mechanism in LDL receptor-deficient mice.
Dichek HL; Johnson SM; Akeefe H; Lo GT; Sage E; Yap CE; Mahley RW
J Lipid Res; 2001 Feb; 42(2):201-10. PubMed ID: 11181749
[TBL] [Abstract][Full Text] [Related]
15. Lecithin:cholesterol acyltransferase deficiency increases atherosclerosis in the low density lipoprotein receptor and apolipoprotein E knockout mice.
Furbee JW; Sawyer JK; Parks JS
J Biol Chem; 2002 Feb; 277(5):3511-9. PubMed ID: 11719520
[TBL] [Abstract][Full Text] [Related]
16. Comparison of human apoA-I expression in mouse models of atherosclerosis after gene transfer using a second generation adenovirus.
Tsukamoto K; Hiester KG; Smith P; Usher DC; Glick JM; Rader DJ
J Lipid Res; 1997 Sep; 38(9):1869-76. PubMed ID: 9323596
[TBL] [Abstract][Full Text] [Related]
17. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice.
Shi W; Wang X; Wong J; Hedrick CC; Wong H; Castellani LW; Lusis AJ
Biochem Biophys Res Commun; 2004 Apr; 317(1):223-9. PubMed ID: 15047172
[TBL] [Abstract][Full Text] [Related]
18. Hepatic low-density lipoprotein receptor-related protein deficiency in mice increases atherosclerosis independent of plasma cholesterol.
Espirito Santo SM; Pires NM; Boesten LS; Gerritsen G; Bovenschen N; van Dijk KW; Jukema JW; Princen HM; Bensadoun A; Li WP; Herz J; Havekes LM; van Vlijmen BJ
Blood; 2004 May; 103(10):3777-82. PubMed ID: 14739216
[TBL] [Abstract][Full Text] [Related]
19. The peroxisome proliferator-activated receptor alpha (PPARalpha) agonist ciprofibrate inhibits apolipoprotein B mRNA editing in low density lipoprotein receptor-deficient mice: effects on plasma lipoproteins and the development of atherosclerotic lesions.
Fu T; Mukhopadhyay D; Davidson NO; Borensztajn J
J Biol Chem; 2004 Jul; 279(27):28662-9. PubMed ID: 15123680
[TBL] [Abstract][Full Text] [Related]
20. ApoB-48 and apoB-100 differentially influence the expression of type-III hyperlipoproteinemia in APOE*2 mice.
Hinsdale ME; Sullivan PM; Mezdour H; Maeda N
J Lipid Res; 2002 Sep; 43(9):1520-8. PubMed ID: 12235184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
